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ABSRACT 
The South African national calibration facility is currently not equipped for mammography, 
dose-measuring equipment.  A therapy X-ray machine was used as a calibration unit at the 
national secondary standards dosimetry laboratory (SSDL) for medium and low energy X-ray, 
therapy calibrations.  It is not necessarily intuitive that the latter calibrations are applicable to 
diagnostic X-ray beams generated by high frequency generators.  The response of measuring 
equipment calibrated in a therapy X-ray beam, compared to its response in a diagnostic or 
clinical mammography unit, is unknown. 
 
The aim of the research was to investigate whether there was a measurable difference between 
the X-ray beam qualities available for low energy diagnostic radiology and radiation therapy, 
i.e. up to 100 kV.  The beam qualities studied included both mammography and conventional 
diagnostic radiography, i.e. nominally 20 kV to 100 kV.  The diagnostic and therapy X-ray 
tubes under investigation had different target-filter combinations, inherent filtration and 
theoretically, different X-ray spectra.  
 
Practically, spectrometry of X-ray beams is not possible because of the sophistication of the 
instrumentation, comprehensive analyses being very time consuming and not practically 
applicable to the clinical environment (Kharatti and Zarrad, 2003). Furthermore, not all 
SSDL’s or Hospitals have access to spectral analysers.  Clinical beam quality is instead 
specified in terms of both the tube peak voltage and the half-value layer (HVL), the thickness 
of material that will reduce the maximum output of the X-ray beam to 50%.  
 
The goal was to compare measured HVLl’s to the ones recommended by the International 
Electro technical Commission (IEC-61267, 2005) for available mammography beam qualities.  
The method was validated using attenuation curves.  The attenuation curves were then used to 
derive the suitability of the X-ray spectra for calibration of mammography ionisation chambers 
(Waggener and Blough, 1999). One of the low energy therapy units was found to be suitable 
for introducing a regional calibration service for mammography.  
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INTRODUCTION 
Wilhelm Conrad Roentgen discovered X-rays on 8 November 1895, while experimenting with 
a discharge tube and noticing a glow on a piece of glass covered with zinc sulphide. Roentgen 
called the undiscovered radiation X-rays, the “X” being the established symbol for an unknown 
quality.  By the 28 November 1895, he had thoroughly investigated the properties of these rays 
and had prepared a manuscript describing his experiments (Krane K S, 1988).  In recognition 
of his outstanding contribution to science, Wilhelm Conrad Roentgen was awarded the first 
Nobel Prize for Physics in 1901.  
 
Today physicians use techniques learned from nuclear physics experiments to perform 
diagnosis and therapy in the human body. “None other field of science comes to mind in which 
theory encompasses such a broad spectrum, ranging from the most microscopic to the cosmic, 
neither is there another field in which direct applications of basic research contain the ultimate 
limits to be beneficial or detrimental”(Krane K S, 1988). 
 
Soon after the discovery of X-rays and their application in medicine, it was realised that this 
radiation could be dangerous.  A quantitative relationship between the radiation and its 
physical and biological effects needed to be established.   This entailed definition and 
acceptance of a suitable unit for measuring X-ray energy. 
 
In diagnostic radiology, there has been an increased demand for clinical radiation absorbed 
dose measurements (dosimetry).   Radiation, measurement accuracy, requirements for 
diagnostic radiology is usually more stringent than those for health physics and less than those 
for therapy (Sunde, 1992).  In diagnostic radiology, different beam qualities have been applied 
as compared to those for radiation therapy.  Quantities such as organ and effective dose are of 
interest and the uncertainties allowed are much larger in radiology.  However, these quantities 
still refer to radiation received by human tissue and are analogous to absorbed dose and kerma 
(energy absorbed or transferred per unit mass of material) in a phantom in radiotherapy 
dosimetry. 
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Dosimetry requires a clear definition of the incident beam quality.  Traditionally, beam quality 
for X-rays is specified by the peak tube operating voltage of the X-ray machine and the first 
half-value layer (HVL1). “The first half-value layer, is defined as the thickness of the specified 
material, which attenuates the air kerma or air kerma rate in the beam to one half of its original 
value measured without any absorber. The contribution of all scattered radiation, other than 
any which might be present in the beam concerned, is determined to be excluded” 
(ICRU report 74, 2005). In practice HVL1, is the thickness of material that will reduce the  
X-ray beam energy to 50%.  Reduction of X-ray beam output occurs because the low energies, 
having little penetrating power, are easily attenuated in the material through which they pass.  
Different X-ray beams may under certain circumstances has the same HVL1 but differ in the 
second half-value layer (HVL2) because of the heterogeneity of the X-ray beam spectrum.  The 
heterogeneity of the X-ray beam spectrum can be expressed in terms of the heterogeneity 
coefficient (HC), that is the ratio of the HVL1 to the HVL2 (Zoetelief et al, 1996). 
The HC for a homogenous X-ray beam is unity. A heterogeneous X-ray beam generally has a 
HC less than 1.00 (Zoetelief et al, 1996).  The reason for this phenomenon is that the X-ray 
beam hardens with additional filtration and therefore the HVL2 is always thicker than the 
HVL1. The beam quality of an X-ray beam is also affected by other parameters related to 
typical diagnostic and therapeutic X-ray machines e.g. different target/filter combinations, 
inherent filtration, collimation, scatter, geometric factors, etc.  
 
The ideal would be an international protocol of standard recommendations for dosimetry in 
Diagnostic Radiology.  Standardised quantities and units applicable to diagnostic radiography, 
as well as the practical aspects of accurate measurement are however still outstanding.  The 
above requirements were recognised by the SSDL of the IAEA/WHO during a meeting of the 
Scientific Committee, 1988: “ Dosimetry measurements of diagnostic radiology, radiation 
protection and environmental exposures do not require the accuracy of therapy-level 
measurements, but do require a coherent relationship to the international measurement system” 
(Freitas and Drexler, 1992).  These include the definition and acceptance of various 
application-specific dosimetric quantities and units, and include the establishment of national 
diagnostic radiology calibration facilities.  Currently there is no official international protocol  
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addressing dosimetry in diagnostic radiology although the IAEA (IAEA-CN-96/39) and the 
IEC (IEC- 61267, 2005) are currently addressing this.  
 
Medical Exposures and Population dose 
Medical ionising radiation from diagnostic X-ray procedures contributes about 90 % to the 
population dose from man-made sources (Pernicka et al, 2000).  Medical exposures are 
however, not the source of the highest radiation dose to the general population. Radon is the 
main contributor to doses from environmental radiation.  
There is a larger possibility that gamma rays will pass through an individual’s body from 
environmental sources, like soil and building materials and inside the human body, potassium-
40 atoms disintegrate emitting beta particles and gamma rays.  The latter radiation is grouped 
under natural radiation, contributing by far the largest percentage to the annual dose of the 
population (Martin A and Harbison S A, 1986). 
 
Risks associated with Medical Exposure 
Experimental evidence of a “safe level of radiation” for prevention of the two most important 
long-term radiation effects, namely carcinogenesis and mutagenesis is non-existent.  It is 
important that the risks associated with medical examinations are therefore expressed more 
quantitatively.  When diagnostic X-rays are used correctly and doses are controlled carefully, 
risks are acceptable within the broader context of both the clinical value of the diagnostic 
information and the risks associated with normal daily living. The detrimental effects of 
radiation arising from diagnostic radiology are currently estimated to be small in comparison 
with the potential benefits resulting from the diagnostic information gained (Rainbow et al, 
1992). 
 
The use of mammography has increased rapidly in many countries.  As the female breast 
seems to be a comparatively radiosensitive organ, optimisation of the radiographic procedure is 
crucial (Thilander et al, 1992).  There is a small but significant risk of radiation-induced 
carcinogenesis associated with the mammography examination and it is important that it is 
estimated (Carlsson and Dance, 1992).   
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Limitation of Medical Exposure 
Since medical X-ray examinations contribute greatly to the population dose from man-made 
radiation sources, a requirement exists to optimise the dose, the design and use of X-ray 
imaging systems (Zoetelief et al, 2003).  Dose limitation is a responsibility of all participants 
involved in medical exposures and that entails establishing, using and assessing dose to 
determine national diagnostic reference levels (DRL’s) (ICRP 60, 1991).  Measurement of the 
dosimetric parameters related to the performance of the equipment plays a predominant role in 
determining the lowest possible dose to either the patient or the staff. (Zoetelief et al, 2003). 
 
Radiation Measurements and Instrument Performance  
The European Council Directive 97/43/EURATOM (Directive 84/466 Euratom, 1997) on 
health protection of individuals against the dangers of ionising radiation in relation to medical 
exposures provides various measures in order to control patient dose from radio-diagnosis 
including mammography.  Dosimeters are important instruments to assess this dose (Witzani J, 
2004). An additional objective of dosimetry in medical imaging is the assessment of equipment 
performance.  Dosimetry for medical X-ray imaging includes the need for international 
standardisation on the practical aspects of instrument calibration and clinical measurement 
methodology in addition to international recommendations on appropriate radiation quantities 
and units. (Zoetelief et al, 2003).  
 
The role of the ICRU, IAEA and IEC 
The present situation in dosimetry for medical imaging indicates clearly the need for 
international recommendations on appropriate diagnostic radiation quantities and units. The 
International Commission on Radiation Units and Measurements (ICRU) defines application 
specific quantities for dosimetry in medical X-ray imaging, new symbols for these units and 
recommendations for the specification of X-ray beams in terms of both radiation quality and 
intensity (ICRU, Report 74, 2005).  Table 1 shows different radiation quantities recommended 
for mammography and their application with reference to the patient and radiation worker 
(Zoetelief et al, 2003).  
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Table 1: Quantities for Dosimetry in Medical X-ray Imaging 
Radiation 
Quantities 
____________ 
Air kerma 
Free-in-air 
 
Air kerma-area 
product  
     Patient related 
     Quantities  
____________________ 
   Incident air kerma 
(without backscatter) 
 
    Entrance air kerma 
(including backscatter) 
   Worker related 
   Quantities   
________________
 Organ dose 
 
 
  Effective dose 
 
 
The International Atomic Energy Agency (IAEA) is currently compiling and testing an 
international code of practice for dosimetry in diagnostic radiology.  The main objectives are to 
achieve and maintain a high level of quality in dosimetry, to improve the implementation of 
traceable standards at the national level and to ensure the control of dose in medical X-ray 
imaging, worldwide (Zoetelief et al, 2003).  The IAEA is emphasizing the practical aspects of 
establishing calibration facilities at SSDL’s in order to disseminate a higher accuracy in 
clinical diagnostic dosimetry. 
 
Rosser (Rosser, 1998) showed that if only generating tube potential and HVL represented 
beam quality, there was little consensus in the beam qualities for low- and medium-energy 
radiotherapy units throughout the UK when comparing the Hospitals with the National 
Physical Laboratory (NPL) beam qualities.  
 
The International Electrical Commission, IEC, also recommended RQA-M qualities but in 
most cases, they are not used (IEC-61267, 2005). The standard radiation qualities 
recommended for mammography calibrations, are listed in table 2. 
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Table 2: Characterization of standard RADIATION QUALITIES 
               RQR-M 1 to RQR-M 4. 
 
Standard Radiation 
Quality 
X-RAY TUBE 
VOLTAGE 
in kV 
First HALF-VALUE 
LAYER 
In mm Aluminium 
RQR-M 1 25 0.28+/- 0.02 
RQR-M 2 28 0.31+/- 0.02 
RQR-M 3 30 0.33+/- 0.02 
RQR-M 4 35 0.36+/- 0.02 
 
The standard radiation conditions for the RQR-M series are relevant to: 
• An emitting target of molybdenum (Mo), 
• An X-ray tube voltage with a ripple of not more than 4% and 
• A total filtration of 0.032mm +/- 0.002mm Mo in the X-ray source assembly 
 
The Role of Secondary Standards Dosimetry Laboratory (SSDL) 
In South Africa, the aim is to establish a diagnostic radiology calibration facility and develop 
national DRL’s (SAF/6/010). The SSDL situated at the South African Council for Scientific 
and Industrial Research (CSIR) National Metrology Laboratory (NML), currently calibrates 
most of the national measuring equipment used in therapy and radiation protection but no 
diagnostic radiology service is offered currently. 
  
The objectives of the SSDL are to calibrate field radiation measuring instruments, provide 
traceability from primary standard dosimetry laboratories (PSDLs) and advise on all aspects of 
ionising radiation metrology. Services of PSDLs are evolving constantly to keep pace with 
advances in dosimetry.  
 
 A direct consequence of the latter is that each national or regional SSDL must adapt its work 
to provide the best results under the different circumstances. Currently an instrument is 
calibrated at a range of appropriate beam qualities available at the CSIR-NML, and the 
response is determined as a function of the peak voltages and the HVL1 of the laboratory unit. 
The user then interpolates between these calibration points in the field. These calibrations are 
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valid for two years and a calibration certificate is issued for the specific measuring equipment. 
The calibration certificate is an official document used in the clinical environment as an 
indication of the performance of the field-measuring instrument. Calibrations are directly 
traceable to primary standards held by Primary Standards Dosimetry Laboratories (PSDLs).  
Several PSDLs have demonstrated mutual equivalence of their primary standards for most 
radiation beam qualities employed in radiology (Zoetelief et al, 2003).  The primary standards 
for radiation qualities should be developed to match the requirements of the clinical application 
(Zoetelief et al, 2003). 
 
In South Africa, the SSDL has a technical co-operation project with the IAEA to set up 
diagnostic radiology capabilities. The main objectives of the project are: 
• To realize a national measurement standard in the field of diagnostic radiology 
traceable to the SI units. 
• To set up a facility to produce diagnostic radiology X-ray beams in line with IAEA 
Code of Practice for diagnostic radiology and IEC-61267 in order to disseminate 
traceability from the abovementioned national measurement standard, thereby enabling 
the delivery of controlled radiation doses in hospitals. 
• To set up a system to disseminate traceability from the abovementioned national 
measurement standard in line with the ISO/IEC 17025 and the IAEA Code of Practice 
on dosimetry in diagnostic radiology. 
 
Low- energy therapy X-ray beams 
The history of radiotherapy with reference to low energy X-ray beams dates back to the 
beginning of 1900’s.  Conventional kilovoltage X-ray therapy machines were used for external 
beam radiotherapy in the treatment of superficial lesions. Low energy therapy X-ray machines 
operate at tube voltages up to100 kV. This type of beam produces a very rapidly decreasing 
depth dose.  The skin surface is maximally irradiated but the underlying tissues are spared to an 
increasing degree with depth.  Treatment is limited to about 1-2 mm of tissue and complete 
absorption of the beam is within 20 mm of soft tissue (Kahn F M, 1992). 
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A range of beam qualities is normally available from the commercial suppliers of kilovoltage 
units, and the choice is in principle, arbitrary. Relative dosimetry is then obtained from 
interpolation of tabulated beam data available (Br.J.Radiol.Suppl 25,1996) or (Rosser K E, 
1998), for instance. Little standardisation therefore exists between clinical units in general. 
 
Low-energy diagnostic X-ray beams 
Most diagnostic X-ray beams are operated at peak tube voltages ranging from 20-150 kV. 
Different diagnostic examinations and procedures require the availability of this range of tube 
voltage.  Conventional diagnostic examinations are performed at 50- 150 kV. The image 
contrast is obtained from the differential X-ray attenuation by bone (high atomic number 
atoms), air and soft tissue (low atomic number atoms).  The amount of beam filtration also 
plays a minor role in optimising patient dose against image quality. In general, the only 
restriction in beam quality is the requirement of a minimum of 2.5 mm Al total tube filtration.   
The low-energy range of diagnostic X-ray beams of 20-40 kV peak tube voltage is exclusively 
applicable to mammography, an examination that is designed especially for detecting breast 
pathology.  In mammography, the average tissue (glandular) dose is determined from measured 
kerma (free in air) and various correction and conversion factors. The latter mentioned factors 
can be obtained from published tables that provide information of the breast entrance skin 
dose, X-ray tube target/filter combinations employed e.g. Mo/Mo, Mo/Al, Mo/Rh, Rh/Rh, 
W/Al, etc., beam quality (HVL), breast thickness, compression and the age of the patient 
(Kharrati and Zarrad, 2003). 
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OBJECTIVES AND JUSTIFICATION 
  
Nationally measuring equipment (ion chambers and electrometers) is calibrated at the CSIR- 
NML, using a constant voltage laboratory, therapy X-ray machine.  It is not necessarily 
intuitive that the latter unit would be applicable to clinical diagnostic X-ray beams generated 
by high frequency generators of different configurations. 
  
This research was undertaken to establish the difference in beam quality between locally-
available low-energy diagnostic radiology and radiation therapy X-ray machines with different 
target-filter combinations and inherent filtrations and theoretically, different X-ray spectra. 
This investigation attempted to identify whether the recommended mammography beam 
qualities could then be simulated in order to introduce national mammography ionisation 
chamber calibrations. 
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METHODS AND MATERIALS 
 
Four different X-ray machines were investigated, namely two clinical mammography units and 
two low-energy therapy X-ray machines. The therapy units were operated at constant tube 
current for all measurements. One of the latter units was the national SSDL unit. The other 
therapy X-ray machine was a clinical unit. Details of the X-ray units and their parameter 
settings used in this work are summarised in Table 3, below.  
 
Table 3: Characteristics of Diagnostic and Therapy X-ray Machines  
 
 
The experimental research entailed collection of attenuation data through known thicknesses of 
high purity (99.9%) aluminium filters (attenuators) for all beams. HVL1 and HVL2 were 
measured and the HC was derived.   
 
MANUFACTURER     
AND MODEL  
 
TARGET-
FILTER 
COMBINATION 
 
ADDED 
FILTRATION 
 
APPLIED                TUBE 
VOLTAGE           OUTPUT / 
    kVp                     CURRENT   
 
Philips Mammo  
Diagnost UCTM 
Mo/Mo 
Mo/Al 
 
0.15 mm Mo 
0.15 mm Al 
      26 
      36 
   63 mAs 
   16 mAs 
 
Bennett Contour 
M-CTRTM 
Mo/Mo 
Mo/Rh 
 
0.15 mm Mo  
0.15 mm Rh  
      36 
      34 
   16 mAs 
   24 mAs 
 
Philips RT 100TM 
Clinical Therapy 
X-ray Unit 
W/Al 
 
0.15 mm Al  
0.30 mm Al 
0.40 mm Al 
0.55 mm Al 
0.78 mm Al 
1.25 mm Al 
1.75 mm Al 
      20 
      30 
      37 
      45 
      55 
      70 
    100 
   10 mA 
   10 mA 
   10 mA 
   10 mA 
   10 mA 
   10 mA   
     8 mA 
Pantak 
Laboratory X-ray 
Unit 
W/Al 2 mm Be       50 
      60 
      70 
    100 
   20 mA 
   20 mA 
   20 mA 
   20 mA 
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EXPERIMENTAL CONDITIONS 
 
The measurements on the mammography units were done with a PTW UNIDOS-E 
electrometer and a 1.0 cc parallel-plate ionisation chamber M 77334, with a calibration 
certificate issued by PTW Freiburg Germany [Certificate No. 025019]. This ionisation 
chamber is rated as being suitable as a diagnostic dosemeter for radiography measurements, 
including mammography. Its mammography calibration range is from 25 kV to 35 kV, with 
HVLs ranging between 0.26 mm Al to 0.65 mm Al. The calibration factor for the 1 cc flat 
mammography ionisation chamber: 
                                Na = 1.964 E +07 Gy/C 
 
The measurements on the therapy units were done with a PTW IQ4 electrometer and a 0.6 cc 
ionisation chamber M 23333-1608 calibrated at the national SSDL. This ionisation chamber is 
rated as being suitable as a therapy dosemeter. Its calibration range suitable for the research 
done is given in table 4. 
 
Table 4: Calibration Data for IQ4 Dosemeter applicable to Low-Energy Therapy 
              X-ray beams. 
 
     
 
 
 Beam 
Quality 
 
 
kV 
 
Beam Filtration: 
Inherent (mm 
Al)  +  
Additional (mm 
Perspex + mm 
Al)  
 
HVL1 
 
 
 
mm Al 
 
  
Air-kerma 
 
 
 
Gy / displayed V 
          
   
Air-
kerma 
rate 
 
mGy /min 
 
Calibration 
Factor 
 
  
E+09 Gy / C 
 
 
  50 0.11 + 4.6 + 0.34 1 mm 
Al 
0.0475 +/- 2%         83  435.90  
 
100 0.11 + 4.6 + 0.74 4 mm 
Al 
0.0460 +/- 2%      109  422.14  
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HVL MEASUREMENTS   
Figure 1 illustrates the schematic arrangements of the apparatus for the HVL-measurements for 
the therapy X-ray apparatus.  
 
Owing to the ability to manoeuvre the X-ray tube mounting, the experimental apparatus 
consisted of a laboratory optical bench with mountings to support the lead diaphragm and 
aluminium filters. The 0.6 cc ionisation chamber was used for monitoring the X-ray beam 
attenuation measurements. The narrow beam or “good geometry” condition was the main 
requirement to produce accurate attenuation measurement data. In practice this requirement 
was fulfilled by limitation of the X-ray beam divergence with the aid of a 50 cm FSD (film to 
source distance) applicator that limited the radiation field to a radius of 2.5 cm at the aperture 
of the diaphragm. The 2.2 cm aperture in the lead diaphragm further limited the radiation field 
to just beyond the outer dimensions of the sensitive volume of the ionisation chamber to ensure 
minimal contribution from scattered radiation to the measuring chamber. The alignment of the 
set-up as well as the centring of the ionisation chamber was done by attaching an X-ray film 
into a fixed chamber holder. Exposure at the lowest tube load showed a circular pattern that 
was comparable with both the centre of the diaphragm and ionisation chamber. Aluminium 
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filters (attenuators) of 99.9% purity according to ISO 2092, were positioned midway between 
the source and the ionisation chamber for the therapy X-ray beams. 
Fixed tube loadings (exposure settings) were used to establish the HVL1 and HVL2. 
 
Figure 2 illustrates the schematic arrangements of the apparatus for the HVL-measurements for 
the mammography X-ray apparatus 
 
                    
Figure 2: Schematic of the HVL measurements for the mammography  
                  Beams [European Protocol, 1996] 
 
In the case of the diagnostic mammography X-ray beams, the 1.0 cc ionisation chamber was 
placed on top of the breast support with its centre 4.4 cm above the cassette table, 6.0 cm from 
the chest wall edge and centred laterally. The compression plate was placed between the 
detector and the X-ray tube. The manual exposure mode was selected. A lead diaphragm 5 mm 
thick with an aperture small enough to limit the radiation to just beyond the outer  
dimensions of the ionisation chamber, was used. The lead diaphragm was placed on top of the 
compression paddle approximately 30.0 cm from the focal spot (European Protocol, 1996). 
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The latter arrangement satisfied the conditions for good geometry.  X-ray films were exposed 
during the set-up stage to ensure alignment of the beam to the sensitive volume of the 
ionisation chamber.  
The current IAEA recommendation for HVL measurements for mammography requires that 
the detector be positioned more above the table to avoid backscattered radiation to reach 
ionisation chamber. The distance from the chest wall is slightly less than used in this work. 
Measurements would have been different due to different geometrical arrangements but final 
result the same. 
  
Aluminium filters (attenuators) of 99.9% purity according to ISO 2092 were positioned 
between the source and the ionisation chamber for the mammography X-ray beams. In this 
case, a source-chamber distance of at least 60 cm was used owing to the physical restriction 
imposed by the clinical unit. Fixed tube loadings (exposure settings) were used to establish the 
HVL1 and HVL2. Two different target-filter combinations per mammography unit were 
investigated. 
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GRAPHYCAL ANALYSIS 
 
 
The computation of the attenuation data was based on the following theory. 
The attenuation of a homogeneous photon beam is exponential and given by the formula: 
                                Kd = KO e⎯ μt
       ………………………………………………… (1)              
 Where,  
Kd  = measurement with an attenuator thickness t in the beam 
KO = measurement with no attenuator in the beam  
μ   = the linear attenuation coefficient 
 t   = thickness of the attenuator 
 
The linear attenuation coefficient is a quantitative measurement of the attenuation of the air 
kerma or air kerma rate per unit thickness of the specified material present in a homogeneous 
photon beam. The linear attenuation coefficient represents fractional reduction of beam energy  
per unit thickness of the attenuating material present in the beam.  
 
From equation (1) it can be derived that when the first half-value layer (HVL1 causes a 
decrease of 50% of Ko), the HVL1 is then given by the equation: 
 
                   HVL1 = ln 2 / μ  ………………………………………… (2)   
                                                    
A graphical analysis of the computed attenuation curves was done from which the HVL1, 
HVL2 and HC values were obtained per beam quality. 
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RESULTS 
 
The therapeutic and mammography (diagnostic) data obtained were analysed according to the 
HVL1, HVL2 and HC per beam quality. Since this research attempted to identify whether the 
IEC-recommended mammography beam qualities could be simulated, the IEC data points  
(Table 2) are also shown.  
 
Figure 3 shows the HVL1 values obtained for each X-ray machine over the selection of  
available peak tube voltages 
 
Figure 3:  Graph of HVL1 versus Peak tube voltage (kVp) for all the units studied, including 
the IEC calibration points. 
 
The PANTAK, laboratory X-ray machine used at the CSIR NML for calibration of therapy 
measuring equipment was unstable at beam qualities lower than 50 kVp. The purpose of the 
Laboratory X-ray machine was originally to provide calibrations for low- and medium-energy 
therapy dosimetry. The output from this unit at energies below 50 kVp was unstable and it was 
therefore considered unsuitable for further investigation in this work.  
 
The HVL1 values of the RT100TM were close enough to exercise regression in order to 
examine the possibility of adapting the unit for mammography calibrations.  
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Figure 4 is an expanded view of the energy range of interest for this research. Only the clinical 
X-ray machines and the IEC-recommended beam qualities are indicated. Clearly, the RT100TM 
required little adaptation to simulate the mammography calibration points.  
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Figure 4:  Graph of HVL1 versus Peak Tube Voltage (kVp) 
 
An attempt to add further specification to beam quality was performed in terms of the HVL2 
values. Figure 5 shows HVL2 as a function of peak tube voltage over the energy range of   
interest. 
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Figure 5:  Graph of HVL2 versus Peak Tube Voltage (kVp) 
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After determination of the HVL1 and HVL2 values for the different X-ray beam spectra, the HC 
(homogeneity coefficient) was calculated. The mean value and standard deviation of the HC for all the 
mammography beams was calculated to be 0.48 +/- 0.00 and for the RT100TM, 0.49 +/- 0.03. The 
homogeneity coefficient for the full X-ray beam energy range was calculated as 0.49 +/- 0.01. 
      
Manipulation, by shifting of the RT100TM raw data was then carried out in order to adjust its HVL1 to 
match the best fit of the IEC data points together with the clinical mammography units’ data points. Figure 
6 shows the normalised electrometer readings versus the attenuator (filter) thicknesses per available beam 
quality relevant to the mammography energy range. 
  
Mathematical functions were used, supplied by MATHEMATICA soft ware, for determining the best line 
fit through the data points in order to determine the required increase or decrease in the HVL1 and HVL2 
values. This mathematical manipulation is illustrated by figure 6.  
 
Figure 6:  Graph of Normalised Electrometer Readings versus Filter Thickness (mm Al) 
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The RT100TM data points obtained for 20 kVp, 30 kVp and 37 kVp were fit to a fourth degree  
polynomial. The fitted polynomial was found to be significant with R2 = 0.9997 at 37 kVp and  
R2 = 0.9990 at 30 kVp. The filter thickness required to produce the required HVL1 could then be 
computed. A second fourth degree polynomial function of the form x = b0 +b1y+ b2y2+ b3y3+ b4y4 
was also fit to the data and these approximations were found to be significant. The filter thickness 
was found to be -0.1 mm Al at 37 kVp and +0.1 mm Al at 20 kVp and 30 kVp.  
 
Figure 7 shows the calculated HVL1 data of the RT100TM obtained from the change to the 
filter thickness. It can be seen that the RT100TM data points would then fit to the mean value of 
the measured clinical data and the IEC recommended points. 
 
 
Figure 7:  Graph of corrected RT100TM HVL1* versus Peak Tube Voltage (kVp) 
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Figure 8 similarly illustrates the impact of this change in filtration to the HVL2 values. 
 
 
  Figure 8:  Graph of corrected RT 100TM HVL2* versus Peak Tube Voltage (kVp) 
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Uncertainty of Measurements 
 
The method used in this report for estimating the uncertainty of measurement is approved by 
the Comite International des Poids et Measures (CIPM) in 1981. According to the Technical 
Reports Series No. 374 (IAEA, TRS No.374, 1994), the uncertainty associated with a 
measurement is a parameter that characterizes the dispersion of the values. This parameter is 
normally an estimated standard deviation. The estimation of an uncertainty might be carried 
out by some known methods called either Type A or B uncertainty. 
   
Type A is where a series of measurements have been made, the so-called observed values. The 
best estimate is then given by the arithmetic mean value (average measurement) and the scatter 
of the observed values around their mean is reflected by the standard deviation. 
Type B is the method where there are many sources of measurement uncertainty that cannot be 
estimated by repeated measurements. Examples of these include not only unknown, although 
suspected, influences on the measurement process, also pressure and temperature differences, 
physical data from the literature, correction factors, etc. 
 
According to the CIPM, method type B standard uncertainties must be estimated so that they 
correspond to standard deviations. Both types A and B are estimated standard deviations 
therefore, they are combined using statistical rules for combining variances 
(the sum of the standard deviations squared). 
 
The overall uncertainty, U (L), was given by: 
                            U (L)  = k {(the sum of the standard deviations squared)/m}
 1/2
, 
where k is the confidence level:……………    k = 2.0, and 
          m is the number of beam qualities:….    m = 7  (THERAPY clinical) 
                                                                           m = 4  (THERAPY non-clinical) 
                                                                           m = 4  (DIAGNOSTIC) 
The uncertainty of the calibration factor of the measuring equipment was  +/- 2%. 
The contributors for the clinical therapy X-ray machine were: 
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• Air pressure……………………………………………………0.3 
• Temperature and Humidity……………………………………0.3 
• Field homogeneity including homogeneity of the added filter..0.5 
• Stability of the operating voltage…………………………….. 0.5 
The overall uncertainty, U (L), was estimated to be: 
                   U (L) = +/- {[(0.3) 2+ (0.3) 2  + (0.5) 2 + (0.5) 2] /7} 
1/2
 
                            =  +/- 0.3 
Under laboratory conditions, the uncertainty contributors for the laboratory therapy X-ray 
machine, were: 
• Air pressure……………………………………………………0.3 
• Temperature and Humidity……………………………………0.3 
• Field homogeneity including homogeneity of the added filter..0.5 
• Stability of the operating voltage…………………………….. 0.5 
• Energy dependence of the chamber…………………………..0.05 
The overall uncertainty, U (L), was estimated to be: 
                       U (L) = +/- {[0.3) 2+ (0.3) 2  + (0.5) 2 + (0.5) 2 + (0.05) 2] /4} 
1/2
 
                               = +/- 0.4 
Typical sources of error for the mammography HVL measurements are given below (Wagner, 
et al): 
• Effective thickness of attenuators…………………………………..+/-0.04 
• Monitored output of X-ray source……………………………….…+/-0.07 
• Attenuator placement………………………………………………+/-0.03 
• Position in field…………………………………………………….+/-0.05 
• Energy dependence of the chamber………………………………..+/-0.03 
                              U (L) = +/-{[(0.04) 2+ (0.07) 2  + (0.03) 2 + (0.05) 2]/4} 
1/2 
 
                                        = +/-0.05 
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DISCUSSION  
The use of mammography has increased rapidly in many countries. In diagnostic radiology, 
there has been an increased demand for more accurate clinical dosimetry.  Dosimetry requires a 
clear definition of the incident beam quality. Currently there are no officially, published 
international protocols addressing dosimetry in diagnostic radiology. 
 
The low-energy range of diagnostic X-ray beams of 20-40 kV peak tube voltage is exclusively 
applicable to mammography, an examination that is designed especially for detecting breast 
pathology. Measurement of the dosimetric parameters related to the performance of the 
equipment plays a predominant role in determining the lowest possible dose. An additional 
objective of dosimetry in medical imaging is the assessment of equipment performance.  
 
In conventional diagnostic radiology, similar beam qualities have been applied to those 
employed in radiation therapy. Traditionally, the combination of peak tube operating voltage of 
the X-ray machine and the HVL1 has specified X-ray beam quality. The different X-ray 
machines used in this work intuitively produced quite different beam qualities owing to 
differences in their different target/filter combinations, pre-set radiographic factors, added 
filtration, inherent filtration, anode angulations and configuration.  
 
Assisting in the establishment of a national calibration facility for diagnostic radiology 
dosimetry was the main goal of this study. The research done focussed on mammography 
energies. The use of mammography has increased rapidly and there is a demand for more 
accurate clinical dosimetry. Mammography is one of the diagnostic techniques that contribute 
to the patient dose (Witzani et al, 2003) and a significant risk of potential radiation induced 
carcinogenesis is associated with it (Dance et al, Pernicka, 2000). The CSIR-NML currently 
uses a constant voltage laboratory therapy X-ray machine for low-energy therapy  
X-ray beam calibrations. 
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From the research undertaken it is clear that the Pantak laboratory X-ray therapy machine 
being used by the national CSIR-NML would be completely inappropriate for mammography 
calibrations without major modifications. The instability of this unit at these low peak tube 
voltages made the unit very unsuitable for accurate calibrations of low dose measuring 
equipment. A better correlation was found between the clinical X-ray therapy units and the 
range of mammography beams investigated.     
 
The RT100TM clinical therapy X-ray machine could be adapted by modifying its added 
filtration to function as a calibration unit. This option could be exercised at little cost and the 
beam quality reconfirmed.  
 
For the calibration of dosimeters used exclusively in mammography, only standard radiation 
qualities produced by a Mo-anode are defined in IEC-61267, 2005. The latter document then 
further specifies beam quality only by the generating peak tube voltage and the associated 
HVL1. A more elaborate system of beam quality specification from the International 
community, which includes at least the HVL2, would further support this work. The results 
confirm that the radiation beam qualities produced by the RT100TM therapy X-ray machine 
could be adapted to those recommended by the IEC for mammography. Experimental 
confirmation of this would support the use of this unit at the SSDL facility. This work could 
then also be expanded to peak tube voltages up to 100 kVp, to include calibration requirements 
for other diagnostic modalities. 
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CONCLUSIONS 
 
¾ There was a measurable difference between clinical X-ray beam qualities and the 
national laboratory unit used historically for therapy calibrations purposes.  
 
¾ The constant voltage X-ray machine at the CSIR NML could not be used for calibration 
of mammography ionisation chambers. 
 
¾ An expanded International specification of beam quality would support this work. 
 
¾ The equivalence in the sensitivity and response of the different ionisation chambers in 
both therapeutic and diagnostic beams needs further investigation.  
 
¾ X-ray machines with intuitively quite different beam qualities could be modified to 
produce equivalent beam quality in terms of the existing IEC specifiers, by 
manipulating beam filtration accordingly 
 
¾ The introduction of a national calibration facility for mammography does not require 
the immediate purchase of a dedicated clinical unit, if the mammography dosimeters to 
be calibrated do not have significant energy dependence. 
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